Evidence map›Paper›PMID 41661266›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2026

[Atrial tachycardia after previous ablation-right atrial, left atrial, biatrial].

Anastasia Falagkari, Reza Wakili

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anastasia FalagkariUniversitäres Herz- und Gefäßzentrum, Goethe Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland. anastasia.falagkari@herz-frankfurt.de.
Reza WakiliUniversitäres Herz- und Gefäßzentrum, Goethe Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCatheter-assisted ablation of supraventricular tachycardia, especially of atrial fibrillation, often results in atrial tachycardia (AT) in the further course. ATs are favored by incomplete linear lesions, scarring of the atria or persistent pulmonary vein connections, and vary in incidence depending on the type of the preceding procedure.

objectivesThis article discusses different forms of postablation AT in terms of diagnosis, treatment options, and perspectives for prevention and effective treatment. MATERIALS AND

methodsOverview-based review of the literature and case-based experiences from our own center on incidence, mapping methods, and ablation strategies as well as emerging technologies. RESULTS AND

conclusionThe reported incidence of postablation ATs varies widely (4-36%), depending on patient selection and procedural complexity. Invasive diagnostics are mainly based on ultra-high-resolution mapping methods, while classical electrophysiological maneuvers are less reliable in this patient population. The therapy of choice is reablation, as drug options are less effective. Depending on the mechanism of AT, focal or linear ablation strategies are preferred, with variable success and more frequent recurrences than with initial ablations. Newer catheter designs and improved lesion control are gaining importance. A technically precise and completely transmural initial ablation remains a central predictor of long-term rhythm stability. Multimodal approaches and individualized strategies are key to the future to sustainably reduce the incidence and recurrence of postablation AT.

Indexed as

Atrial FibrillationCatheter AblationHeart AtriaPostoperative ComplicationsTachycardia, Ectopic AtrialTachycardia, SupraventricularBody Surface Potential MappingEvidence-Based MedicineHumansTreatment OutcomePostablationPulmonary vein isolationRecurrenceScarringThree-dimensional mapping

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.